We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




2011 BIO International Convention Sets Attendance Records

By LabMedica International staff writers
Posted on 06 Jul 2011
The 2011 BIO International Convention, the largest global event for the biotechnology industry, set new records in partnering meetings, and increased international attendance and participation. More...
The convention program included panel sessions on the latest scientific, policy and business opportunities and challenges facing the industry. The conference, hosted by the Biotechnology Industry Organization (BIO; Washington DC, USA) in Washington DC (USA), drew 15,626 industry leaders from the US and other 65 countries.

“The 2011 BIO International Convention was an enormous success, bringing together leaders from industry, government, and academia who are working to solve some of the sector’s biggest challenges,” said President and CEO of BIO Jim Greenwood. “Bringing the global biotech industry to Washington DC, [USA], gave us the critical opportunity to showcase to key policymakers our industry’s promise to offer real solutions to the most pressing global challenges such as curing disease, reducing health care costs, combating hunger, discovering alternative forms of energy and creating high-wage jobs. We continue to advocate for a policy and regulatory environment that will support innovation and inspire industry growth.”

Keynote sessions included the former UK Prime Minister Tony Blair, US Senator John Barrasso, former US Senator Tom Daschle, Vermont Governor Howard Dean, and Republican political strategist Karl Rove. The Convention program featured more than 125 sessions across 15 tracks, including Global Innovations and Markets, Health Policy and Reimbursement, Biosecurity, Business Development, Food and Agriculture, and Biofuels, and Biobased Chemicals.

The BIO Business Forum hosted a record-breaking 21,183 partnering meetings between 2,410 companies and featured 157 company presentations. According to the BIO Business Forum Partnering Report there is high demand for Phase I assets as well as Central Nervous System (CNS), immunology, and metabolic therapeutic areas compared to 2010. In addition, the 2010 top-three-highest interest therapeutic areas in including cardiovascular, oncology, and respiratory categories are now all in the bottom half of 2011's top 10 areas.

The 2012 BIO International Convention will take place during June 18-21, 2012, at the Boston Convention and Exhibition Center in Boston (MA, USA).

Related Links:
BIO International Convention
Biotechnology Industry Association



Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Serological Pipet Controller
PIPETBOY GENIUS
New
Varicella Zoster Virus Assay
LIAISON VZV Assay Panel (IgG HT, IgM)
New
Enterovirus Test
Quanty Enterovirus System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Ear wax could be a possible screening medium for Parkinson’s disease (Photo courtesy of 123RF)

Earwax Test Accurately Detects Parkinson’s by Identifying Odor Molecules

Current tests for Parkinson’s disease (PD) rely heavily on clinical scales and neuroimaging, which are often subjective, expensive, and ill-suited for routine screening. Since most treatments only slow... Read more

Molecular Diagnostics

view channel
Image: Cord blood proteomics can identify biomarkers of early-onset neonatal sepsis (Photo courtesy of JCI Insight (2025). DOI: 10.1172/jci.insight.193826)

Umbilical Cord Blood Test Can Detect Early Sepsis in Preterm Infants

Diagnosing early onset sepsis (EOS) in preterm infants is particularly difficult due to the lack of specific clinical signs, leading to widespread use of antibiotics while awaiting culture results.... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: NGS can detect one tumor cell among a million healthy cells from a simple blood sample (Photo courtesy of Shutterstock)

New Tool Detects Breast Cancer Relapses Five Years in Advance

Relapse detection in patients with solid tumors—particularly hormone receptor-positive (HR+) breast cancer—remains a major clinical challenge, as many patients initially respond well to treatment but later... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.